These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33861793)

  • 21. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
    Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
    BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data.
    Dix Junqueira Pinto G; de Souza Viana L; Scapulatempo Neto C; Vicente Serrano S
    J Immunol Res; 2016; 2016():9839685. PubMed ID: 27747247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of the tumor immune microenvironment in synovial sarcoma.
    Oike N; Kawashima H; Ogose A; Hotta T; Hatano H; Ariizumi T; Sasaki T; Yamagishi T; Umezu H; Endo N
    Cancer Sci; 2018 Oct; 109(10):3043-3054. PubMed ID: 30133055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
    Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
    J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.
    Yu D; Cheng J; Xue K; Zhao X; Wen L; Xu C
    Pathol Oncol Res; 2019 Oct; 25(4):1437-1443. PubMed ID: 30361911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab.
    Tamura R; Tanaka T; Ohara K; Miyake K; Morimoto Y; Yamamoto Y; Kanai R; Akasaki Y; Murayama Y; Tamiya T; Yoshida K; Sasaki H
    Cancer Sci; 2019 Feb; 110(2):499-508. PubMed ID: 30467920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-related PD-L1 expression in Kaposi sarcoma tumor microenvironment.
    Joest B; Kempf W; Berisha A; Peyk P; Tronnier M; Mitteldorf C
    J Cutan Pathol; 2020 Oct; 47(10):888-895. PubMed ID: 32310306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma.
    Liu CQ; Xu J; Zhou ZG; Jin LL; Yu XJ; Xiao G; Lin J; Zhuang SM; Zhang YJ; Zheng L
    Br J Cancer; 2018 Jul; 119(1):80-88. PubMed ID: 29921949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.
    Xu JY; Wang WS; Zhou J; Liu CY; Shi JL; Lu PH; Ding JL
    Pancreas; 2019 Aug; 48(7):904-912. PubMed ID: 31268976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
    Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
    Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
    Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
    Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
    Ye X; Zhang J; Lu R; Zhou G
    Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
    Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
    Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes of oral leukoplakia on the irradiated or nonirradiated mucosa among survivors of head and neck cancer in the papulation where practice of betel nut chewing and cigarette smoking are widespread.
    Yang SW; Lin CY; Lee YS; Huang SM
    BMC Oral Health; 2024 Jul; 24(1):851. PubMed ID: 39061032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy.
    Chen TW; Huang KC; Chiang SF; Chen WT; Ke TW; Chao KSC
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1043-1053. PubMed ID: 30874889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
    El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.